Arcadia Biosciences Inc. (RKDA)
Arcadia Biosciences Statistics
Share Statistics
Arcadia Biosciences has 1.37M shares outstanding. The number of shares has increased by 0.31% in one year.
| 1.37M |
| 0.31% |
| 0.15% |
| 99.99% |
| n/a |
| 41 |
| 0.37% |
Short Selling Information
The latest short interest is 19.34K, so 1.42% of the outstanding shares have been sold short.
| 19.34K |
| 1.42% |
| 1.42% |
| 1.46 |
Valuation Ratios
The PE ratio is -1.15 and the forward PE ratio is -1.97. Arcadia Biosciences's PEG ratio is 0.02.
| -1.15 |
| -1.97 |
| 1.6 |
| 0.8 |
| 1.3 |
| -0.84 |
| 0.02 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for Arcadia Biosciences.
| n/a |
| n/a |
| n/a |
| n/a |
Financial Position
The company has a current ratio of 3.61, with a Debt / Equity ratio of 0.02.
| 3.61 |
| 3.25 |
| 0.02 |
| -0.02 |
| -0.02 |
| 0 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| n/a |
| n/a |
| n/a |
| $560,555.56 |
| $-782,000 |
| 9 |
| 0.37 |
| 3.28 |
Taxes
| 8K |
| -0.19% |
Stock Price Statistics
The stock price has increased by 58.53% in the last 52 weeks. The beta is 0.52, so Arcadia Biosciences's price volatility has been higher than the market average.
| 0.52 |
| 58.53% |
| 3.65 |
| 3.89 |
| 67.3 |
| 11,002 |
Income Statement
In the last 12 months, Arcadia Biosciences had revenue of 5.04M and earned -7.04M in profits. Earnings per share was -5.16.
| 5.04M |
| 2.08M |
| -3.65M |
| -7.04M |
| -7.5M |
| -7.61M |
| -5.16 |
Balance Sheet
The company has 4.24M in cash and 155K in debt, giving a net cash position of 4.09M.
| 4.24M |
| 155K |
| 4.09M |
| -278.88M |
| 12.99M |
| 6.63M |
Cash Flow
In the last 12 months, operating cash flow was -9.63M and capital expenditures -16K, giving a free cash flow of -9.64M.
| -9.63M |
| -16K |
| -9.64M |
| -7.07 |
Margins
Gross margin is 41.27%, with operating and profit margins of -72.31% and -139.5%.
| 41.27% |
| -72.31% |
| -85.41% |
| -139.5% |
| -148.64% |
| -72.31% |
| -191.14% |
Dividends & Yields
RKDA does not appear to pay any dividends at this time.
| n/a |
| n/a |
| n/a |
| n/a |
| n/a |
| n/a |
Analyst Forecast
The average price target for RKDA is $6, which is 26.6% higher than the current price. The consensus rating is "Buy".
| $6 |
| 26.6% |
| Buy |
| 1 |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| n/a |
| n/a |
| n/a |
| n/a |
Stock Splits
The last stock split was on Mar 1, 2023. It was a backward split with a ratio of 1:40.
| Mar 1, 2023 |
| backward |
| 1:40 |
Scores
| -29.22 |
| 2 |